144 related articles for article (PubMed ID: 15911985)
1. Use of proteomics to study chemosensitivity.
Poland J; Wandschneider S; Urbani A; Bernardini S; Federici G; Sinha P
Methods Mol Med; 2005; 111():267-81. PubMed ID: 15911985
[TBL] [Abstract][Full Text] [Related]
2. Proteomic profiling of MCF-7 breast cancer cells with chemoresistance to different types of anti-cancer drugs.
Chuthapisith S; Layfield R; Kerr ID; Hughes C; Eremin O
Int J Oncol; 2007 Jun; 30(6):1545-51. PubMed ID: 17487377
[TBL] [Abstract][Full Text] [Related]
3. Methods in functional proteomics: two-dimensional polyacrylamide gel electrophoresis with immobilized pH gradients, in-gel digestion and identification of proteins by mass spectrometry.
Bernard KR; Jonscher KR; Resing KA; Ahn NG
Methods Mol Biol; 2004; 250():263-82. PubMed ID: 14755094
[No Abstract] [Full Text] [Related]
4. Proteomic analysis of the basic proteins in 5-fluorouracil resistance of human colon cancer cell line using the radical-free and highly reducing method of two-dimensional polyacrylamide gel electrophoresis.
Tanaka S; Sakai A; Kimura K; Yoshida H; Fushitani H; Ogata A; Miyamoto A; Fukushima M; Wada A; Tanigawa N
Int J Oncol; 2008 Aug; 33(2):361-70. PubMed ID: 18636157
[TBL] [Abstract][Full Text] [Related]
5. New insights into neuroblastoma cisplatin resistance: a comparative proteomic and meta-mining investigation.
D'Aguanno S; D'Alessandro A; Pieroni L; Roveri A; Zaccarin M; Marzano V; De Canio M; Bernardini S; Federici G; Urbani A
J Proteome Res; 2011 Feb; 10(2):416-28. PubMed ID: 21128686
[TBL] [Abstract][Full Text] [Related]
6. Proteome analysis of multidrug resistance in vincristine-resistant human gastric cancer cell line SGC7901/VCR.
Yang YX; Xiao ZQ; Chen ZC; Zhang GY; Yi H; Zhang PF; Li JL; Zhu G
Proteomics; 2006 Mar; 6(6):2009-21. PubMed ID: 16525997
[TBL] [Abstract][Full Text] [Related]
7. [Proteomic analysis of human ovarian cancer cell lines and their platinum-resistant clones].
Yan XD; Pan LY
Zhonghua Fu Chan Ke Za Zhi; 2006 Sep; 41(9):584-7. PubMed ID: 17181965
[TBL] [Abstract][Full Text] [Related]
8. Chromatofocusing fractionation and two-dimensional difference gel electrophoresis for low abundance serum proteins.
Qin S; Ferdinand AS; Richie JP; O'Leary MP; Mok SC; Liu BC
Proteomics; 2005 Aug; 5(12):3183-92. PubMed ID: 16035113
[TBL] [Abstract][Full Text] [Related]
9. Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry.
Yu KH; Rustgi AK; Blair IA
J Proteome Res; 2005; 4(5):1742-51. PubMed ID: 16212428
[TBL] [Abstract][Full Text] [Related]
10. [Screening proteins related to retinoic acid resistance by proteomic analysis].
Qin H; Liu T; Yang JL; Huang X; Liu B; Song X; Zhao X; Wei YQ
Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(8):520-5. PubMed ID: 17459200
[TBL] [Abstract][Full Text] [Related]
11. Proteomics with two-dimensional gel electrophoresis and mass spectrometry analysis in cardiovascular research.
You SA; Wang QK
Methods Mol Med; 2006; 129():15-26. PubMed ID: 17085802
[TBL] [Abstract][Full Text] [Related]
12. Comparative proteomic analysis of the esophageal squamous carcinoma cell line EC109 and its multi-drug resistant subline EC109/CDDP.
Wen J; Zheng B; Hu Y; Zhang X; Yang H; Li Y; Zhang CY; Luo KJ; Zang X; Li YF; Guan XY; Fu JH
Int J Oncol; 2010 Jan; 36(1):265-74. PubMed ID: 19956855
[TBL] [Abstract][Full Text] [Related]
13. Identification of 14-3-3sigma as a contributor to drug resistance in human breast cancer cells using functional proteomic analysis.
Liu Y; Liu H; Han B; Zhang JT
Cancer Res; 2006 Mar; 66(6):3248-55. PubMed ID: 16540677
[TBL] [Abstract][Full Text] [Related]
14. Proteomic analysis of liver cancer cells treated with suberonylanilide hydroxamic acid.
Tong A; Zhang H; Li Z; Gou L; Wang Z; Wei H; Tang M; Liang S; Chen L; Huang C; Wei Y
Cancer Chemother Pharmacol; 2008 Apr; 61(5):791-802. PubMed ID: 17593366
[TBL] [Abstract][Full Text] [Related]
15. Unbiased examination of changes in plasma membrane proteins in drug resistant cancer cells.
Rahbar AM; Fenselau C
J Proteome Res; 2005; 4(6):2148-53. PubMed ID: 16335961
[TBL] [Abstract][Full Text] [Related]
16. Alterations in gamma-actin and tubulin-targeted drug resistance in childhood leukemia.
Verrills NM; Po'uha ST; Liu ML; Liaw TY; Larsen MR; Ivery MT; Marshall GM; Gunning PW; Kavallaris M
J Natl Cancer Inst; 2006 Oct; 98(19):1363-74. PubMed ID: 17018783
[TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of the Sulfolobus solfataricus P2 proteome.
Chong PK; Wright PC
J Proteome Res; 2005; 4(5):1789-98. PubMed ID: 16212434
[TBL] [Abstract][Full Text] [Related]
18. Identification of human hepatocellular carcinoma-related biomarkers by two-dimensional difference gel electrophoresis and mass spectrometry.
Lee IN; Chen CH; Sheu JC; Lee HS; Huang GT; Yu CY; Lu FJ; Chow LP
J Proteome Res; 2005; 4(6):2062-9. PubMed ID: 16335951
[TBL] [Abstract][Full Text] [Related]
19. Search for novel proteins involved in the development of chemoresistance in colorectal cancer and fibrosarcoma cells in vitro using two-dimensional electrophoresis, mass spectrometry and microsequencing.
Sinha P; Hütter G; Köttgen E; Dietel M; Schadendorf D; Lage H
Electrophoresis; 1999 Oct; 20(14):2961-9. PubMed ID: 10546834
[TBL] [Abstract][Full Text] [Related]
20. A reference map of human nasopharyngeal squamous carcinoma proteome.
Li F; Xiao Z; Zhang P; Li J; Li M; Feng X; Guan Y; Chen Z
Int J Oncol; 2007 May; 30(5):1077-88. PubMed ID: 17390009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
